Librede Inc. Awarded Highly Competitive Phase II SBIR Grant From NIH

Librede Cannabinoid Map

CALIFORNIA: Librede, an early stage biotechnology company, has been awarded a $1,490,000 Phase II Small Business Innovative Research Grant (SBIR) from the National Center for Complementary and Integrative Health (NCCIH), part of the National Institutes of Health (NIH), to further develop and scale their proprietary yeast-based cannabinoid production platform. The NIH SBIR program is a highly Read the full article…

CBD And Legal Cannabis Market On The Rise

CBD and Legal Cannabis Market On the Rise

NEW YORK: A recent report by Arcview Market Research indicates that consumer spending on legal cannabis in North America is outpacing previous estimates. The report projects that retail cannabis sales will grow 33% from 2016, to about $10 billion this year. The data published projects that by 2021 the legal cannabis market will reach a value of $24.5 billion and at Read the full article…

FDA Grants ‘Priority Review’ Of Plant-Derived CBD Extract

If Epidiolex achieves FDA-approval, analysts suggest the product could retail for between $30,000 to $60,000 annually.

DISTRICT OF COLUMBIA: Representatives of the US Food and Drug Administration will undertake a ‘priority review‘ of data specific to the safety and efficacy of Epidiolex, a standardized, plant-derived CBD extract formulated by a British pharmaceutical company. The review is scheduled to be completed by June 27, 2018. Phase III clinical trial data shows that Epidiolex Read the full article…

HempMeds Wins Product Registration Hearing In Puerto Rico, Begins Selling First-Ever Approved Nutraceutical Product

HempMeds wins approval to sell RSHO in PR

CALIFORNIA: Medical Marijuana, Inc., the first publicly traded cannabis company in the United States, has announced that its subsidiary HempMeds had its product registrations affirmed in Puerto Rico, enabling the company to continue selling its CBD hemp oil products freely throughout the U.S. territory. This major milestone marks another historic first for RSHO as the first and only legally registered cannabis Read the full article…

Book Review: The ABCs of CBD By Shira Adler

The ABCs of CBD

By Tracey Henry The ABC’s of CBD: The Essential Guide for Parents (And regular folks too), a new book by author, activist and devoted “Canna Mom” Shira Adler, is all about CBD but it just might change how you think about cannabis in general. Written in clean, factual, and often humorous prose, this book is Read the full article…

Isodiol Signs LOI To Import Cannabidiol To Canada From UK With Nuuvera

Isodiol Signs LOI To Import Cannabidiol To Canada From UK With Nuuvera

CANADA:  Isodiol and Nuuvera have agreed to import 99%+ pure, bioactive pharma-grade cannabidiol (‘CBD’) isolate into Canada from Isodiol’s GMP-certified production facility in the United Kingdom.  The product, certified as a pharmaceutical-grade, will be imported into Canada through Nuuvera’s subsidiary, ARA – Avanti Rx Analytics, a Health Canada GMP-certified laboratory holding a dealer license under Read the full article…

The Wink In Weed: Eating High On The Healing Hog (And Heifer)

Move over Slim Jim

Anyone paying attention knows that Slim Jim has lots of company on the grocery store shelves these days.  Jerky and meat snacks — high in protein, low in calories – are gaining popularity as a healthy snack alternative to greasy potato chips.  In fact, Nielsen research company reports that Americans consumed more than $2.8 billion Read the full article…

Level Brands And Isodiol Strike Multimillion-Dollar CBD Products Deal

kathy ireland Heath & Wellness, a Level Brands Business Unit, Enters into License with Isodiol Bringing the Parties Together in a Multimillion-Dollar Cannabidiol (CBD) Products Deal

NORTH CAROLINA: Level Brands has announced a licensing agreement with Vancouver-based Isodiol International to develop consumer products for kathy ireland® Health & Wellness, a licensor to Level Brands, and for Level Brands subsidiary I’M1, the company’s lifestyle brand for men. According to a company press release, Level Brands will receive an initial US$2 million payment in the form of Read the full article…

Study: CBD Effective As Adjunctive Therapy For Schizophrenia

"These findings suggest that CBD has beneficial effects in patients with schizophrenia," authors concluded.

UNITED KINGDOM: The daily administration of CBD (cannabidiol) as an adjunctive therapy mitigates psychotic symptoms in patients with schizophrenia, according to clinical trial data published online ahead of print in The American Journal of Psychiatry. British researchers assessed the adjunctive use of CBD compared to placebo over a six-week period in a randomized trial of 88 schizophrenic patients. Participants ingested 1000mg Read the full article…

World Health Organization: CBD Should Not Be Subject To International Drug Controls

hemp CBD oil

SWITZERLAND: Use of the naturally occurring cannabinoid CBD (cannabidiol) possesses no likely abuse potential and should not be subject to international drug scheduling restrictions, according to recommendations issued this week by the World Health Organization’s (WHO) Expert Committee on Drug Dependence. Stated WHO: “Recent evidence from animal and human studies shows that its use could have some therapeutic value for seizures due Read the full article…